Cargando…

Gene Expression Patterns of Hemizygous and Heterozygous KIT Mutations Suggest Distinct Oncogenic Pathways: A Study in NIH3T3 Cell Lines and GIST Samples

OBJECTIVE: Most gain of function mutations of tyrosine kinase receptors in human tumours are hemizygous. Gastrointestinal stromal tumours (GIST) with homozygous mutations have a worse prognosis. We aimed to identify genes differentially regulated by hemizygous and heterozygous KIT mutations. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachet, Jean-Baptiste, Tabone-Eglinger, Séverine, Dessaux, Sophie, Besse, Anthony, Brahimi-Adouane, Sabrina, Emile, Jean-François, Blay, Jean-Yves, Alberti, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625162/ https://www.ncbi.nlm.nih.gov/pubmed/23593401 http://dx.doi.org/10.1371/journal.pone.0061103

Ejemplares similares

Prognosis and predictive value of KIT exon 11 deletion in GISTs
por: Bachet, J-B, et al.
Publicado: (2009)

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
por: Klug, Lillian R., et al.
Publicado: (2018)

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism
por: Théou-Anton, N, et al.
Publicado: (2006)

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome
por: Brahmi, Mehdi, et al.
Publicado: (2015)

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors
por: Lourenço, Nelson, et al.
Publicado: (2014)

Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice
por: Hayashi, Shuichi, et al.
Publicado: (2017)

Secondary KIT mutations: the GIST of drug resistance and sensitivity
por: Napolitano, Andrea, et al.
Publicado: (2019)

X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
por: Guindo, Aldiouma, et al.
Publicado: (2007)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
por: Nannini, Margherita, et al.
Publicado: (2014)

Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
por: Bachet, Jean-Baptiste, et al.
Publicado: (2010)

KIT mutation in a naïve succinate dehydrogenase‐deficient gastric GIST
por: Brcic, Iva, et al.
Publicado: (2019)

miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT
por: Wang, Yu, et al.
Publicado: (2018)

Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007)

Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
por: Pantaleo, Maria A, et al.
Publicado: (2015)

KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST
por: Klinke, Olaf Karl, et al.
Publicado: (2015)

Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs
por: Tabone-Eglinger, Séverine, et al.
Publicado: (2008)

Mutational Analysis of c-KIT and PDGFRA in Canine Gastrointestinal Stromal Tumors (GISTs)
por: Morini, Maria, et al.
Publicado: (2022)

Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021)

Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
por: Astolfi, Annalisa, et al.
Publicado: (2020)

Optimisation of conditions for detection of activated oncogenes by transfection of NIH 3T3 cells.
por: Lemoine, N. R., et al.
Publicado: (1987)

PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu
Publicado: (1995)

Experimental Metastasis of Oncogene‐transformed NIH 3T3 Cells in Chick Embryo
por: Endo, Yoshio, et al.
Publicado: (1992)

Molecular and functional characterization of a new 3′ end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib
por: Perfetti, Vittorio, et al.
Publicado: (2017)

ETV1 is a lineage-specific survival factor in GIST and cooperates with KIT in oncogenesis
por: Chi, Ping, et al.
Publicado: (2010)

The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

PCDH19 in Males: Are Hemizygous Variants Linked to Autism?
por: Chouery, Eliane, et al.
Publicado: (2023)

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
por: Vincenzi, Bruno, et al.
Publicado: (2022)

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells
Publicado: (1998)

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells.
por: Liu, H. S., et al.
Publicado: (1998)

Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
por: Dufresne, Armelle, et al.
Publicado: (2014)

Erratum to: The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)
por: Nannini, Margherita, et al.
Publicado: (2017)

Targeted Deep Sequencing Reveals Unrecognized KIT Mutation Coexistent with NF1 Deficiency in GISTs
por: Wu, Jinchun, et al.
Publicado: (2021)

KIT-Associated Familial GIST Syndrome: Response to Tyrosine Kinase Inhibitors and Implications for Risk Management
por: Brodey, Alexandra, et al.
Publicado: (2022)

Midkine induces the transformation of NIH3T3 cells.
por: Kadomatsu, K., et al.
Publicado: (1997)

Heterogeneity of the NIH3T3 Fibroblast Cell Line
por: Rahimi, Amir Mohammad, et al.
Publicado: (2022)

A GIST or not a GIST? That is the question
por: Chrysanthos, Nikolaos, et al.
Publicado: (2014)

The enhanced transfer of drug-resistant genes in NIH-3T3 cells transformed by the EJras oncogene.
por: Wong, D., et al.
Publicado: (1988)

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients
por: Moura, David S., et al.
Publicado: (2018)

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
por: Heinrich, Michael C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lnpq1a0hv0pkgpiqk1t42u21qq